Allspring Global Investments
IPSC icon

Allspring Global Investments’s Century Therapeutics IPSC Stock Holding History

Allspring Global Investments’s Portfolio IPSC Stock Details IPSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-7,992
Closed -$41K – 2850
2022
Q4 		$41K Buy
+7,992
New +$75.4K ﹤0.01% 2389
2022
Q2 		– Sell
-13,908
Closed -$175K – 2807
2022
Q1 		$175K Sell
13,908
-1,637
-11% -$21.7K ﹤0.01% 2611
2021
Q4 		$246K Buy
+15,545
New +$292K ﹤0.01% 2578

Other funds holding IPSC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Allspring Global Investments's IPSC Position: Q1 2023 in Review

Allspring Global Investments sold out of Century Therapeutics (IPSC) in Q1 2023, closing a stake of 7,992 shares — an estimated $41K sold.

Allspring Global Investments first reported a position in IPSC in Q4 2021 and held it in 3 quarters. The position peaked at $246K in Q4 2021. 63 funds tracked by Wall St. Rank hold IPSC as of Q1 2023.

  • Allspring Global Investments reported no remaining Century Therapeutics position as of Q1 2023 after selling out during the quarter.
  • Allspring Global Investments sold 7,992 Century Therapeutics shares in Q1 2023, an estimated $41K.
  • Allspring Global Investments first reported a position in Century Therapeutics in Q4 2021 and held it in 3 quarters.
  • Allspring Global Investments's Century Therapeutics position peaked at $246K in Q4 2021.
  • 63 funds tracked by Wall St. Rank held Century Therapeutics as of Q1 2023.

Based on Allspring Global Investments's 13F filing for Q1 2023, filed 13 Apr 2023.